Co-targeting BET proteins along with key pro-tumor pathways, such as IKBKE or STAT3 signaling, has shown potential to disrupt macrophage polarization and inflammatory signaling simultaneously (64, 101). The gene discussed is STAT3; the disease is neoplasm.